-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
Apellis Pharmaceuticals, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2019 to Q1 2024.
- Apellis Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $293K, a 13.1% increase year-over-year.
- Apellis Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $773K, a 49.3% decline from 2022.
- Apellis Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $1.52M, a 38.2% increase from 2021.
- Apellis Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $1.1M, a 79.7% decline from 2020.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)